Annexon Appoints Industry Veteran Dr. Rick Artis to Chief Scientific…
BRISBANE, Calif., Jan. 6, 2023 (GLOBE NEWSWIRE) — Annexon, Inc. ANNX, a clinical-stage biopharmaceutical company developing a new class of complementary medicines for patients with